Navigation Links
Eurofins MWG Operon and Genomatix launch strategic alliance

Eurofins MWG Operon, an expert in next generation sequencing (NGS) and Genomatix Software GmbH, a leading company in complex analysis and interpretation of such NGS data, announce their decision to combine their expertise and join forces to offer state-of-the art solutions for comprehensive genome analysis and re-sequencing project services.

"We are pleased to cooperate with a partner offering such a high level of expertise in understanding and interpretation of complex biological processes. The special know-how of Genomatix with its rich proprietary data background will have an enormous impact on our service offerings to our customers and will add a further layer of quality to strengthen our position as the leading provider for next generation sequencing services" says Bruno Poddevin, Eurofins Senior Vice President, Genomic Services.

Klaus May, Chief Business Officer of Genomatix, says: "Eurofins MWG Operon is an outstanding quality and service oriented company with friendly, bright and competent people. I am highly satisfied about this partnership, which represents the first one-stop-shop for complete project services, from experimental planning, wet-lab work and data analysis, to data interpretation and deep biological understanding. Together, we offer our customers cutting edge science and technology without the need for them to make major investments in equipment, infrastructure and manpower."

Both partners have already successfully worked together to gain several significant projects where applicative know-how and powerful bioinformatic capabilities have been key for effective project consulting and execution.


Contact: Dr. Martin Seifert
Genomatix Software GmbH

Page: 1

Related biology news :

1. Verizon Business to Provide Global IP for Eurofins Scientific
2. Genomatix gives a hand in the analysis of Wayne States sequencing projects
3. University of Michigan installs second Genomatix Genome Analyzer
4. MCTP bought Genomatix NextGen Sequencing analysis stations
5. Genomatix gets patent for comparative genomics method
6. CRG buys Genomatix Next Generation Sequencing analysis solution
7. Boehringer Ingelheim uses Genomatix Next Generation Sequencing data analysis systems
8. Genomatix joins Illumina-Connect program
9. Announcing launch of FRAX version 3.1
10. Ten years on, Wellcome Trust launches study of 10,000 human genomes in UK
11. American Sociological Association launches first-of-its-kind teaching tool
Post Your Comments:
(Date:5/12/2016)... , a brand of Troubadour Research & ... Q1 wave of its quarterly wearables survey. A particular ... a program where they would receive discounts for sharing ... "We were surprised to see that so many ... CEO of Troubadour Research, "primarily because there are segments ...
(Date:4/28/2016)... BANGALORE, India , April 28, 2016 /PRNewswire/ ... product subsidiary of Infosys (NYSE: INFY ), and ... global partnership that will provide end customers with ... banking and payment services.      (Logo: ... area for financial services, but it also plays a fundamental ...
(Date:4/26/2016)... , April 27, 2016 ... the  "Global Multi-modal Biometrics Market 2016-2020"  report to ... ) , The analysts forecast the ... CAGR of 15.49% during the period 2016-2020.  ... number of sectors such as the healthcare, BFSI, ...
Breaking Biology News(10 mins):
(Date:6/27/2016)... --  Ginkgo Bioworks , a leading organism design ... awarded as one of the World Economic Forum,s ... innovative companies. Ginkgo Bioworks is engineering biology to ... in the nutrition, health and consumer goods sectors. ... including Fortune 500 companies to design microbes for ...
(Date:6/24/2016)... ... ... Researchers at the Universita Politecnica delle Marche in Ancona combed medical journal ... Their findings are the subject of a new article on the Surviving Mesothelioma website. ... the blood, lung fluid or tissue of mesothelioma patients that can help point doctors ...
(Date:6/23/2016)... /PRNewswire/ - FACIT has announced the creation of ... company, Propellon Therapeutics Inc. ("Propellon" or "the Company"), ... portfolio of first-in-class WDR5 inhibitors for the treatment ... represent an exciting class of therapies, possessing the ... cancer patients. Substantial advances have been achieved with ...
(Date:6/23/2016)... , June 23, 2016  The Prostate Cancer Foundation (PCF) is ... treatments and faster cures for prostate cancer. Members of the Class of 2016 ... countries. Read More About the Class of 2016 PCF ... ... ...
Breaking Biology Technology: